Ekonomické výsledky

Restrictive blood transfusion practices are associated with improved patient outcomes. (otvorí nové okno)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Zdroj‎: Transfusion 2014;54(10 Pt 2):2753-9.

Označenie‎: PubMed 24995770

Identifikátor digitálneho objektu‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (otvorí nové okno)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (otvorí nové okno)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Zdroj‎: Transfusion 2017;57(6):1347-58.

Označenie‎: PubMed 28150313

Identifikátor digitálneho objektu‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (otvorí nové okno)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (otvorí nové okno)

MacLaren R, Sullivan PW.

Zdroj‎: Value Health 2005;8(2):105-16.

Označenie‎: PubMed 15804319

Identifikátor digitálneho objektu‎: 10.1111/j.1524-4733.2005.04006.x

https://www.ncbi.nlm.nih.gov/pubmed/15804319 (otvorí nové okno)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (otvorí nové okno)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Zdroj‎: Transfusion 2015;55(12):2807-15.

Označenie‎: PubMed 26264557

Identifikátor digitálneho objektu‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (otvorí nové okno)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (otvorí nové okno)

Nardi G, Agostini V, Rondinelli B, Russo E, Bastianini B, Bini G, Bulgarelli S, Cingolani E, Donato A, Gambale G, Ranaldi G

Zdroj‎: Crit Care 2015;19:83.

Označenie‎: PubMed 25880548

Identifikátor digitálneho objektu‎: 10.1186/s13054-015-0817-9

https://www.ncbi.nlm.nih.gov/pubmed/25880548 (otvorí nové okno)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (otvorí nové okno)

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C.

Zdroj‎: Health Technol Assess 2013;17(10):1-79.

Označenie‎: PubMed 23477634

Identifikátor digitálneho objektu‎: 10.3310/hta17100

https://www.ncbi.nlm.nih.gov/pubmed/23477634 (otvorí nové okno)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (otvorí nové okno)

Stein DM, Dutton RP, Kramer ME, Scalea TM.

Zdroj‎: J Trauma 2009;66(1):63-72.

Označenie‎: PubMed 19131807

Identifikátor digitálneho objektu‎: 10.1097/TA.0b013e318191bc8a

https://www.ncbi.nlm.nih.gov/pubmed/19131807 (otvorí nové okno)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (otvorí nové okno)

Zilberberg MD, Shorr AF.

Zdroj‎: BMC Health Serv Res 2007;7:138.

Označenie‎: PubMed 17764560

Identifikátor digitálneho objektu‎: 10.1186/1472-6963-7-138

https://www.ncbi.nlm.nih.gov/pubmed/17764560 (otvorí nové okno)

INTENZÍVNA STAROSTLIVOSŤ

Ekonomické výsledky

slovenčina

Ekonomické výsledky

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Restrictive blood transfusion practices are associated with improved patient outcomes. (otvorí nové okno)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (otvorí nové okno)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (otvorí nové okno)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (otvorí nové okno)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (otvorí nové okno)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (otvorí nové okno)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (otvorí nové okno)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (otvorí nové okno)

Výbor pre styk s nemocnicami (VSN)

Informačné balíčky pre lekárov

Videá

Ekonomické výsledky

Vyberte si jazyk

Poslať odkaz